PPT Slide
Time (days)
Log-Rank P = 0.0001
Phase III pivotal OA trials
Hubbard R et al. Arthritis & Rheum1998;41(9) Suppl:982A.
Data on File: Searle (Studies 020, 021 & 054)
time to withrawal due to lack of efficacy
Previous slide
Next slide
Back to first slide
View graphic version